Favorable Reimbursements Policy by Medicare in the Americas to Spur the Demand for Coagulation Testing Devices: New Market Research Report

Renewable energy

 

Technavio, a tech-focused market research firm, has published a new report on the global coagulation testing market, which is expected to grow at a CAGR of close to 6% during the forecast period 2017-2021.

Based on geographical segmentation, Technavio market researchers categorize the global coagulation testing market into the following key regions: the Americas, APAC, and EMEA.

Click here to request a free sample of this report

Global coagulation testing market in the Americas: The US is the largest revenue contributor in this region. There has been an increase in the use of portable and disposable coagulation testing devices for patients in the US. The rise can be attributed to the declining healthcare costs in hospitals due to healthcare reforms in the US.

According to Sapna Jha, a lead analyst at Technavio, specializing in research on in-vitro diagnostics, “The availability of coagulation tests, such as Factor X, activated clotting time, bleeding time, and Protein C tests, will help the market grow. Also, favorable reimbursements policy by Medicare, increase usage of advanced portable and disposable devices, and product innovation by vendors will drive the market growth in the Americas.”

Global coagulation testing market in EMEA: The major revenue contributors to the market in this region are Germany, the UK, Spain, Italy, and France. The increasing prevalence of cardiovascular diseases and the rising awareness of the benefits of using POC coagulation testing products have increased their demand in Europe. The market is witnessing the increasing adoption of coagulation testing products that are portable and can be used at home to prevent hospital stays and reduce costs.

Global coagulation testing market in APAC: Rising awareness of the applications of coagulation testing products among consumers is expected to contribute to the growth of the market in APAC during the forecast period. Technological innovations, increasing aging population, and improvements in healthcare infrastructure are among the significant growth drivers of this market. Local manufacturers in APAC are offering low-cost products, because of which multinational companies are facing threats from these manufacturers.

Ask an analyst to know more about this report

The top vendors operating in the global coagulation testing market are:

  • Roche Diagnostics
  • Alere
  • Abbott Laboratories
  • Siemens Healthcare

Other prominent vendors in the market include Accriva Diagnostics, CoaguSense, Diagon, Helena Laboratories, HemoSonics, iLine Microsystems, Medtronic, Micropoint Bioscience, and Sysmex.

A more detailed analysis is available in the Technavio market research report titled, ‘Global Coagulation Testing Market 2017-2021’. Technavio also customizes reports by other regions and specific segments upon request.

Other related reports:

To read more press releases – click here

For any assistance or query, please contact our media team at:

media@technavio.com
US: +1 630 333 9501
UK: +44 208 123 1770
https://www.technavio.com/